期刊文献+

血肾损伤分子1与β2微球蛋白浓度在妊娠期高血压并发早期肾损伤的诊断价值 被引量:13

Study on the diagnostic value of renal injury molecule-1 and β2-microglobulin concentration in pregnancy induced hypertension with early renal injury
原文传递
导出
摘要 目的探讨肾损伤分子1(renal injury molecule-1,Kim-1)与β2微球蛋白(β2-Microglobulin,β2-MG)浓度在妊娠期高血压疾病(hypertensive disorder of pregnancy,HDP)并发早期肾损伤的诊断价值。方法回顾性分析2017年7月至2018年10月西安市中心医院收治的HDP并发肾损伤的56例孕妇和同期56名正常孕妇的临床资料,HDP并发肾损伤的孕妇为观察组,同期56名正常孕妇为对照组,比较两组孕妇孕30周、32周、34周、36周时血肌酐(serum creatinine,SCr)、Kim-1、β2-MG浓度的差异,并分析Kim-1、β2-MG联合诊断HDP早期肾损伤的价值。结果观察组孕30周、孕32周、孕34周、孕36周时SCr、Kim-1、β2-MG均呈升高趋势,差异有统计学意义(Kim-1:F组内=11.234、β2-MG:F组内=12.852、SCr:F组内=8.308,P均<0.001)。且观察组SCr[孕30周、孕32周、孕34周、孕36周:(75.35±10.32)、(75.41±10.35)、(77.02±10.50)、(87.78±10.64)μmol/L]、Kim-1[孕30周、孕32周、孕34周、孕36周:(5.68±1.50)、(7.56±1.52)、(8.25±1.62)、(9.65±1.76)ng/L]、β2-MG[孕30周、孕32周、孕34周、孕36周:(0.26±0.07)、(0.29±0.08)、(0.75±0.29)、(1.02±0.38)ng/L]均高于对照组SCr[孕30周、孕32周、孕34周、孕36周:(74.37±10.34)、(74.43±10.40)、(75.10±12.52)、(76.80±11.66)μmol/L]、Kim-1[孕30周、孕32周、孕34周、孕36周:(5.31±1.75)、(5.36±1.77)、(5.39±1.60)、(5.41±1.70)ng/L]、β2-MG[孕30周、孕32周、孕34周、孕36周:(0.25±0.07)、(0.26±0.09)、(0.28±0.08)、(0.27±0.08)mg/L],差异有统计学意义(SCr:F组间=10.254、Kim-1:F组间=16.352、β2-MG:F组间=18.221,P均<0.001)。两组在不同分组与不同时间之间存在交互作用(SCr:F交互=15.632、Kim-1:F交互=25.645、β2-MG:F交互=34.251,P均<0.001)。Kim-1联合β2-MG诊断HDP并发早期肾损伤的灵敏度96.43%(54/56)、特异度94.64%(53/56)、准确率95.54%(107/112),明显优于单独使用Kim-1[88.24%(45/51)、92.86%(52/56)、86.61%(97/112)]、β2-MG[81.13%(43/53)、78.57%(44/56)、77.68%(87/112)],差异有统计学意义(P均<0.05)。结论HDP早期肾损伤孕妇血清Kim-1、β2-MG浓度显著升高,可作为产前监控筛查早期肾损伤的可靠指标,联合检测能提高其诊断准确性。 Objective To investigate the diagnostic value of renal injury molecule-1(KIM-1)andβ2-microglobulin(β2-MG)concentration in hypertensive disorder of pregnancy(HDP)complicated with early renal injury.Methods From July 2017 to October 2018,the clinical data of 56 pregnant women with HDP complicated with renal injury and 56 normal pregnant women in the same period in Xi′an Central Hospital were analyzed retrospectively.The pregnant women with HDP complicated with renal injury were the observation group and the 56 normal pregnant women were the control group.The difference of serum creatine(SCr),KIM-1,β2-MG concentration between the two groups at 30,32,34 and 36 weeks of gestation was compared,and the value of KIM-1,β2-MG combined diagnosis of early renal injury in HDP was analyzed.Results At 30,32,34 and 36 weeks of gestation,Kim-1,β2-MG and SCr in the observation group increased significantly(Kim-1:Fintra-group=11.234,β2-MG:Fintra-group=12.852,SCr:Fintra-group=8.308;all P<0.001).In the observation group,SCr(30 weeks,32 weeks,34 weeks,36 weeks:(75.35±10.32),(75.41±10.35),(77.02±10.50),(87.78±10.64)μmol/L),Kim-1(30 weeks,32 weeks,34 weeks,36 weeks:(5.68±1.50),(7.56±1.52),(8.25±1.62),(9.65±1.76)ng/L),β2-MG(30 weeks,32 weeks,34 weeks,36 weeks:(0.26±0.07),(0.29±0.08),(0.75±0.29),(1.02±0.38)ng/L)were all higher than those of control group SCr(30 weeks,32 weeks,34 weeks,36 weeks:(74.37±10.34),(74.43±10.40),(75.10±12.52),(76.80±11.66)μmol/L),Kim-1(30 weeksL,32 weeks,34 weeks,36 weeks:(5.31±1.75),(5.36±1.77),(5.39±1.60),(5.41±1.70)ng/L),β2-MG(30 weeks,32 weeks,34 weeks,36 weeks:(0.25±0.07),(0.26±0.09),(0.28±0.08),(0.27±0.08)mg/L),the difference was statistically significant(SCr:Fintergroup=10.254,Kim-1:Fintergroup=16.352,β2-MG:Fintergroup=18.221;all P<0.001).There were interaction between the two groups at different time(SCr:Finteraction=15.632,Kim-1:Finteraction=25.645,β2-MG:Finteraction=34.251;all P<0.001).The sensitivity,specificity and accuracy of Kim-1 combined withβ2-MG were 96.43%(54/56),94.64%(53/56)and 95.54%(107/112),respectively.It was significantly better than Kim-1 alone(88.24%(45/51),92.86%(52/56),86.61%(97/112)),β2-MG alone(81.13%(43/53),78.57%(44/56),77.68%(87/112)),the difference was statistically significant(all P<0.05).Conclusion The serum levels of KIM-1 andβ2-MG in pregnant women with early renal injury of HDP are significantly increased,which can be used as a reliable indicator for prenatal monitoring and screening of early renal injury,and the combined detection can improve the accuracy of diagnosis.
作者 陈小琳 慕婷 雷洁 Chen Xiaolin;Mu Ting;Lei Jie(Department of Nephrology,Xi′an Central Hospital,Shaanxi Province,Xi′an 710002,China)
出处 《中国综合临床》 2020年第3期263-266,共4页 Clinical Medicine of China
关键词 肾损伤分子1 早期肾损伤 联合监测 妊娠期高血压 Β2微球蛋白 肾功能 Kidney injury molecule-1 Early renal injury Combined monitoring Pregnancy hypertension β2-microglobulin Renal function
  • 相关文献

参考文献11

二级参考文献128

  • 1冯惠清,王淑仙,武红利.N-乙酰-β-D-氨基葡萄糖苷酶和随机尿蛋白检测在妊娠高血压综合征中的应用[J].中国综合临床,2006,22(2):174-176. 被引量:3
  • 2孙艳虹,曾智杰,姜傥,高玲,罗美如,范敏珊.血清半胱氨酸蛋白酶抑制剂C在肾病患者肾功能评估中的应用[J].中华肾脏病杂志,2006,22(8):503-504. 被引量:36
  • 3丰有吉,沈铿主编.妇产科学[M].2版.北京:人民卫生出版社,2011:214.215.
  • 4乐杰.妇产科学[M].4版.北京:人民卫生出版社,1997:252
  • 5Xia LH,Bing XG,An XT.Serum cystatin C assay for the detection of early renal impairment in diabetic patients[J].J Clin Lab Anal,2004,18(1):31-35.
  • 6中国高血压防治指南(基层版)编撰委员会,中华人民共和国卫生部疾病预防控制局,卫生部心血管病防治研究中心,等.中国高血压防治指南(2009年基层版)[J].中华高血压杂志,2010,18(1):11-30.
  • 7Wu JT.Advanced glycosylation end products:a new disease marker for diabetes and aging[J].J Clin Lab Anal,1993,7(5):252-255.
  • 8Mussap M,Plebani M.Biochemistry and clinical role of human cystatin C[J].Crit Rev Clin Lab Sci,2004,41(5-6):467-550.
  • 9Moodley J,Gangaram R,Khanyile R,et al.Serum cystatin C for assessment of glomerular filtration rate in hypertensive disorders of pregnancy[J].Hypertens Pregnancy,2004,23(3):309-317.
  • 10Ozer BA,Dursun B,Baykal A,et al.Can cystatin C be a better marker for the early detection of renal damage in primary hypertensive patients?[J].Ren Fail,2005,27(3):247-253.

共引文献167

同被引文献155

引证文献13

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部